Pictet Asset Management (Switzerland)’s Teva Pharmaceuticals TEVA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.64M	Sell	350,285 -13,500	-4%	-$109K	﹤0.01%	871
2023 Q1	$3.22M	Buy	363,785 +18,200	+5%	+$180K	﹤0.01%	861
2022 Q4	$3.15M	Buy	345,585 +8,300	+2%	+$72.4K	﹤0.01%	848
2022 Q3	$2.72M	Buy	337,285 +14,460	+4%	+$128K	﹤0.01%	862
2022 Q2	$2.43M	Sell	322,825 -42,625	-12%	-$371K	﹤0.01%	913
2022 Q1	$3.43M	Buy	365,450 +40,500	+12%	+$338K	﹤0.01%	882
2021 Q4	$2.6M	Sell	324,950 -9,100	-3%	-$82.1K	﹤0.01%	965
2021 Q3	$3.28M	Buy	+334,050	New	+$3.13M	﹤0.01%	923

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TEVA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Teva Pharmaceuticals (TEVA) stake by 3.7% in Q2 2023, selling an estimated $109K and leaving 350,285 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Pictet Asset Management (Switzerland) first reported a position in TEVA in Q3 2021 and has held it in 8 quarters since. The position peaked at $3.43M in Q1 2022. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

Pictet Asset Management (Switzerland) held 350,285 shares of Teva Pharmaceuticals worth $2.64M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 13,500 Teva Pharmaceuticals shares in Q2 2023, an estimated $109K.
Teva Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #871 holding.
Pictet Asset Management (Switzerland) first reported a position in Teva Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Teva Pharmaceuticals position peaked at $3.43M in Q1 2022.
428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.